PL3223799T3 - Sposób otrzymywania kompozycji składnik farmaceutyczny-polimer - Google Patents

Sposób otrzymywania kompozycji składnik farmaceutyczny-polimer

Info

Publication number
PL3223799T3
PL3223799T3 PL15839072T PL15839072T PL3223799T3 PL 3223799 T3 PL3223799 T3 PL 3223799T3 PL 15839072 T PL15839072 T PL 15839072T PL 15839072 T PL15839072 T PL 15839072T PL 3223799 T3 PL3223799 T3 PL 3223799T3
Authority
PL
Poland
Prior art keywords
drug
preparation
polymer composition
polymer
composition
Prior art date
Application number
PL15839072T
Other languages
English (en)
Inventor
Kirit Patel
Original Assignee
Patel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Patel filed Critical Patel
Publication of PL3223799T3 publication Critical patent/PL3223799T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846Poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
PL15839072T 2014-11-30 2015-11-26 Sposób otrzymywania kompozycji składnik farmaceutyczny-polimer PL3223799T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2457MU2014 2014-11-30
PCT/IN2015/050177 WO2016084105A1 (en) 2014-11-30 2015-11-26 A process for preparation of a drug-polymer composition
EP15839072.4A EP3223799B1 (en) 2014-11-30 2015-11-26 A process for preparation of a drug-polymer composition

Publications (1)

Publication Number Publication Date
PL3223799T3 true PL3223799T3 (pl) 2020-06-15

Family

ID=55442843

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15839072T PL3223799T3 (pl) 2014-11-30 2015-11-26 Sposób otrzymywania kompozycji składnik farmaceutyczny-polimer

Country Status (8)

Country Link
US (1) US10668019B2 (pl)
EP (1) EP3223799B1 (pl)
CN (1) CN106999442A (pl)
AU (1) AU2015351913B2 (pl)
CA (1) CA2969089A1 (pl)
ES (1) ES2778082T3 (pl)
PL (1) PL3223799T3 (pl)
WO (1) WO2016084105A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019193488A1 (en) 2018-04-06 2019-10-10 Capsugel Belgium Nv Spray drying process for low aspect ratio particles comprising poly[(methyl methacrylate)-co-(methacrylic acid)]
CN114353444B (zh) * 2022-01-14 2023-01-03 成都市海通药业有限公司 一种降低奥硝唑注射液中杂质b的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286489A (en) 1985-08-26 1994-02-15 The Procter & Gamble Company Taste masking compositions
US5084278A (en) 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
US5149775A (en) 1991-01-25 1992-09-22 Eastman Kodak Company Method for purifying high molecular weight vinylpyridine/styrene polymers from solution
JP2000508339A (ja) 1996-10-01 2000-07-04 シーマ・ラブス・インコーポレイテッド 味隠蔽マイクロカプセル組成物及び製造方法
US20050084540A1 (en) 2003-10-17 2005-04-21 Indranil Nandi Taste masking antibiotic composition
CA2549539C (en) * 2003-12-15 2013-02-12 Council Of Scientific & Industrial Research Taste masked pharmaceutical composition comprising ph sensitive polymer
AU2003288706B2 (en) 2003-12-15 2007-08-23 Council Of Scientific And Industrial Research pH sensitive polymer and process for preparation thereof
WO2005056619A1 (en) 2003-12-15 2005-06-23 Council Of Scientific & Industrial Research pH SENSITIVE POLYMER AND PROCESS FOR PREPARATION THEREOF
EP1813268A1 (en) 2006-06-15 2007-08-01 DSMIP Assets B.V. Method for preparing polymeric matrices by radiation in the presence of sensitive pharmaceutical compounds
JP2012528819A (ja) 2009-06-04 2012-11-15 ビーエーエスエフ ソシエタス・ヨーロピア 味マスク活性成分含有口腔内崩壊性投薬形態
US20110142942A1 (en) 2009-12-10 2011-06-16 Monosol Rx, Llc USE OF pH SENSITIVE COMPOUNDS IN TASTE MASKING OF DRUG SUBSTANCES WITHIN ORAL THIN FILM STRIPS
ES2877509T3 (es) * 2011-06-27 2021-11-17 Cristal Delivery B V Sistema de liberación controlada
US20140056981A1 (en) 2012-08-21 2014-02-27 Centro De Investigacion En Quimica Aplicada Method for producing drug-loaded polymeric nanoparticles by polymerization in presence of drugs

Also Published As

Publication number Publication date
AU2015351913A1 (en) 2017-03-09
WO2016084105A1 (en) 2016-06-02
EP3223799B1 (en) 2019-12-18
EP3223799A1 (en) 2017-10-04
CA2969089A1 (en) 2016-06-02
ES2778082T3 (es) 2020-08-07
US20170304205A1 (en) 2017-10-26
AU2015351913B2 (en) 2021-07-15
US10668019B2 (en) 2020-06-02
CN106999442A (zh) 2017-08-01

Similar Documents

Publication Publication Date Title
HRP20201847T1 (hr) Postupak za pripremu spoja diariltiohidantoina
IL251613B (en) A process for the preparation of terprostinil
EP3230280A4 (en) Process for preparation of luliconazole
PT3295941T (pt) Processo para preparar a forma a do grapiprant
IL248267B (en) A process for preparing converted cycloserines
IL246619A0 (en) A process for the recovery of a solid form of a pharmaceutical preparation
EP3174878A4 (en) A process for the preparation of palbociclib
PL3223799T3 (pl) Sposób otrzymywania kompozycji składnik farmaceutyczny-polimer
HUP1400378A2 (hu) Eljárás apixaban elõállítására
IL247443B (en) Process for the preparation of 5-fluorotryptophol
IL241974A0 (en) Process for making erlotinib
HUP1400518A2 (hu) Eljárás tofacitinib elõállítására
HUP1400025A1 (en) New dhydro-oxazinobenzodiazepine compounds a process for their preparation and pharmaceutical compositions containing them